Contact Us  |  About Cerus  |  Site Map  |  Search:
A Single Pathogen Inactivation System for Both Platelets and Plasma The INTERCEPT Blood System™ is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. It is the first system available to treat both platelets and plasma, and simplifies processing by utilizing the same illumination device, process and active compound. This synergistic approach is designed to meet blood center requirements for efficiency, performance and compatibility with both whole blood and apheresis collections. More

  

NEWS & FEATURES

Bacterial Risks Prompt German Safety Measures
(Oct 23) Morered arrow

Cerus Presents Data on Intercept Blood System at AABB Annual Meeting
(Oct 9) Morered arrow


The INTERCEPT Blood Systems for platelets and plasma are CE marked and produced to ISO 13485 Quality Standard.
SIGN UP FOR OUR E-NEWSLETTER INTERCEPT eNews is a bimonthly newsletter with product news and information.

  UNITED STATES RESIDENTS
This site is intended for use by healthcare professionals outside of the United States only. If you are a resident of the United States, please see important information HERE.
© Cerus Corporation. All Rights Reserved.

Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.

Website design by NetPilot Web Solutions
Legal Info  |   Privacy Policy